Sesame Review: A Cash-Pay Marketplace Not Another GLP-1 Subscription

What Is Sesame?

Sesame is a direct-to-patient healthcare marketplace rather than a GLP-1 company. You book a visit with a clinician at a posted cash price and pay for that visit — the same way you might book any other service. Weight loss and GLP-1 care is one of many categories it covers.

That structure produces a very different value proposition. There is no program to enrol in, no membership required to get care, and no minimum commitment. Sesame markets 'self-pay & insurance options' alongside a blunt promise: 'No deductibles, no surprise bills.' Visits are advertised starting at $34, with the company promising care in minutes.

On the medication side, Sesame is oriented toward brand-name products. It lists the Wegovy pill and pen, Zepbound, Ozempic, Mounjaro and Rybelsus, and advertises the Wegovy pill starting at just $149/month with the claim that patients can lose up to 14% of their weight on it. Sesame also operates an optional SesamePlus membership, though its weight-loss pages do not detail what that adds for GLP-1 patients specifically.

Medications Offered & Pricing

Sesame separates the two costs you will pay: the clinician visit, posted from $34, and the medication itself. Only the Wegovy pill has a published monthly figure ($149/month) on the weight-loss page; prices for the other brand-name GLP-1s are not posted there. Because Sesame is a marketplace, visit prices vary by clinician, so the $34 figure is a floor rather than a fixed rate.

Brand-Name or Compounded?

Sesame's listed GLP-1s are brand-name, FDA-approved medications — Wegovy, Zepbound, Ozempic, Mounjaro and Rybelsus. We found no compounded semaglutide or tirzepatide offering.

For patients who want to avoid the compounded market entirely but do not want to pay a $149-or-more monthly membership to a program like Ro or Calibrate, Sesame is one of the few routes to brand-name GLP-1 care with no recurring program fee at all. You pay for a visit; the prescription goes where you fill it.

The advertised $149/month for the Wegovy pill is notable because it is competitive with compounded pricing while being an FDA-approved product. Verify current terms directly with Sesame, since manufacturer cash-pay programs for brand GLP-1s change frequently.

The Consultation Process

Eligibility

• •Clinical eligibility is determined by the individual clinician you book with, not by a program algorithm.
• •Sesame does not publish a BMI threshold for GLP-1 prescribing on its weight-loss pages.
• •Because Sesame is a marketplace, the clinicians available — and therefore what can be prescribed — vary by location.
• •State-by-state availability is not published on the weight-loss page; confirm coverage in your state before booking.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Sesame is not a medication-shipping subscription, so there is no program shipping cadence. Fulfillment depends on the pharmacy you use and, for the advertised Wegovy pill pricing, on the terms of that specific offer. Confirm delivery arrangements at the point of prescribing.

• •Posted cash prices before you book — no surprise billing
• •Direct choice of clinician rather than assignment
• •Care advertised as available in minutes
• •Self-pay and insurance options
• •Optional SesamePlus membership
• •No subscription or minimum commitment for GLP-1 care

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Sesame May Be Best For

• •Patients who want brand-name GLP-1 access without paying a recurring program fee
• •People who already know what they want and just need a prescribing clinician
• •Anyone who dislikes subscriptions and wants to pay per visit
• •Patients specifically interested in the Wegovy pill at the advertised $149/month
• •Self-pay patients who want prices posted before they commit

Limitations

• •Sesame gives you access, not a program. There is no coaching, no monitoring, no dose-titration support and no refill management — if you want a care team, this is the wrong model.
• •Pricing transparency is strong for visits and weak for medication: one published drug price across six listed brand GLP-1s is not enough to plan a budget.
• •Because clinicians set their own prices and availability varies by location, your actual experience may differ substantially from the advertised floor.
• •The absence of published refund and cancellation terms matters most if you take out a SesamePlus membership.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Sesame solves a specific problem well: getting brand-name GLP-1 care without signing up for anything. If you are the kind of patient who resents paying $149 or $199 a month for check-ins and coaching you do not want, booking a $34 visit and walking away with a prescription is a genuinely appealing alternative — and the Wegovy pill at an advertised $149/month is competitive with compounded pricing while being an FDA-approved product.

But you should be clear about what you are not getting. There is no care team, no monitoring, no titration support, no refill management and no shipping. GLP-1 therapy involves months of dose escalation and side-effect management, and Sesame's model leaves all of that to you and whichever clinician you happen to book. That is fine if you are experienced and self-directed; it is a poor fit for a first-time patient.

We would also like to see more prices. Publishing one medication price across six listed brand GLP-1s means most shoppers still cannot budget from the public page. Use Sesame when you want access and autonomy at the lowest possible entry cost, and choose Calibrate or Ro if you want someone helping you actually get through the programme.